Please go to Enter Survey and review David Larwood’s talk entitled "A Clinical Trial Roadmap: Who, What, When, and How – Practices, Perspectives and Personal Insights."
Registration is now open for our May 9th B2DG evening meeting –Liquid Biopsies: A Fundamental Advance in Cancer Care with Mark Jacobstein. Go to to pre-register for a presentation of this potentially ground-breaking personalized medicine technology.

The Bio2Device Group (B2DG) is a premier organization for all San Francisco Bay Area professionals in pharmaceutical, biotech, medical device, diagnostics and other life science industry sectors. Weekly programs are designed to keep members up-to-date with industry news, help them explore other industry sectors, and provide networking opportunities with other life science professionals from all industry sectors and corporate functions. The B2DG also hosts a moderated LinkedIn Group to facilitate communication between members.

Our Next Event

Félix Vega, VMD - Principal Consultant - Preclinical Consultation
05/02/2017 - 8:30am
Sunnyvale City Council Chambers- 456 West Olive Ave., Sunnyvale

This presentation will provide an overview of the use of animal models in preclinical evaluations, primarily of medical devices. We will briefly discuss the regulatory and ethical requirements of animal use, but concentrate on the utility of animal models in various clinical applications ranging from gastrointestinal through endovascular and cardiac devices. The speaker will present issues...

Syndicate content